Jean Gauthier

1.1k total citations
31 papers, 728 citations indexed

About

Jean Gauthier is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jean Gauthier has authored 31 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Jean Gauthier's work include HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (4 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Jean Gauthier is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (4 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Jean Gauthier collaborates with scholars based in Canada, France and Egypt. Jean Gauthier's co-authors include Pierre L. Beaulieu, George Kukolj, Ginette McKercher, Fred Saad, Anne‐Marie Mes‐Masson, Sylvie Goulet, Jean‐Simon Duceppe, Marc‐André Poupart, Yves Bousquet and James Gillard and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jean Gauthier

31 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Gauthier Canada 14 245 206 204 194 194 31 728
Gulrez Fazal Canada 13 371 1.5× 275 1.3× 207 1.0× 256 1.3× 267 1.4× 16 810
Anke Krüger Germany 12 223 0.9× 310 1.5× 132 0.6× 85 0.4× 52 0.3× 19 953
Peter W. White Canada 21 454 1.9× 576 2.8× 417 2.0× 219 1.1× 287 1.5× 46 1.3k
Junxing Shi United States 16 213 0.9× 244 1.2× 257 1.3× 202 1.0× 450 2.3× 39 864
Chung-Chi Lee Taiwan 16 61 0.2× 121 0.6× 235 1.2× 212 1.1× 112 0.6× 40 1.1k
Blanda Stammen United Kingdom 12 140 0.6× 195 0.9× 420 2.1× 273 1.4× 505 2.6× 15 1.4k
Xiu Yu United States 9 226 0.9× 137 0.7× 346 1.7× 92 0.5× 185 1.0× 11 839
Ginette McKercher Canada 14 495 2.0× 288 1.4× 196 1.0× 164 0.8× 502 2.6× 30 982
Vincent Lévêque United States 28 803 3.3× 643 3.1× 549 2.7× 219 1.1× 659 3.4× 41 1.7k
Laval Chan Canada 16 427 1.7× 274 1.3× 332 1.6× 284 1.5× 384 2.0× 27 968

Countries citing papers authored by Jean Gauthier

Since Specialization
Citations

This map shows the geographic impact of Jean Gauthier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Gauthier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Gauthier more than expected).

Fields of papers citing papers by Jean Gauthier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Gauthier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Gauthier. The network helps show where Jean Gauthier may publish in the future.

Co-authorship network of co-authors of Jean Gauthier

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Gauthier. A scholar is included among the top collaborators of Jean Gauthier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Gauthier. Jean Gauthier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pezel, Théo, Emmanuelle Berthelot, Jean Gauthier, et al.. (2020). Epidemiological characteristics and therapeutic management of patients with chronic heart failure who use smartphones: Potential impact of a dedicated smartphone application (report from the OFICSel study). Archives of cardiovascular diseases. 114(1). 51–58. 12 indexed citations
3.
Abisror, Noémie, A. Mékinian, Véronique Le Guern, et al.. (2018). FRI0508 Analysis of risk factors of adverse obstetrical outcome in patients with takayasu arteritis. Annals of the Rheumatic Diseases. 77. 781–782. 1 indexed citations
4.
Gauthier, Jean. (2006). [The heart and doping].. PubMed. 99(11). 1126–9. 2 indexed citations
5.
Kukolj, George, Graham A. McGibbon, Ginette McKercher, et al.. (2005). Binding Site Characterization and Resistance to a Class of Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase. Journal of Biological Chemistry. 280(47). 39260–39267. 100 indexed citations
6.
Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2004). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency. Bioorganic & Medicinal Chemistry Letters. 14(4). 967–971. 74 indexed citations
7.
Beaulieu, Pierre L., Michael Bös, Yves Bousquet, et al.. (2003). Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorganic & Medicinal Chemistry Letters. 14(1). 119–124. 82 indexed citations
8.
Gauthier, Jean. (2002). [Blood doping and cardiovascular consequences].. PubMed. 31(40). 1904–8. 2 indexed citations
9.
Llinàs‐Brunet, Montse, Dale R. Cameron, Jean‐Marie Ferland, et al.. (1999). Phosphotyrosine-Containing Dipeptides as High-Affinity Ligands for the p56lck SH2 Domain. Journal of Medicinal Chemistry. 42(4). 722–729. 10 indexed citations
10.
Gauthier, Jean. (1999). Writing to families. Psychiatric Bulletin. 23(7). 387–389. 2 indexed citations
11.
Mes‐Masson, Anne‐Marie, et al.. (1998). Analysis of the p16 tumor suppressor gene in early‐stage prostate cancer. Molecular Carcinogenesis. 21(3). 164–170. 6 indexed citations
12.
Mes‐Masson, Anne‐Marie, et al.. (1998). Analysis of thep16 tumor suppressor gene in early-stage prostate cancer. Molecular Carcinogenesis. 21(3). 164–170. 34 indexed citations
13.
Duan, Jianmin, Michel Liuzzi, Michelle Lambert, et al.. (1998). Antiviral Activity of a Selective Ribonucleotide Reductase Inhibitor against Acyclovir-Resistant Herpes Simplex Virus Type 1 In Vivo. Antimicrobial Agents and Chemotherapy. 42(7). 1629–1635. 35 indexed citations
14.
Mes‐Masson, Anne‐Marie, et al.. (1996). Overexpression of her-2/neu in human prostate cancer and benign hyperplasia. Cancer Letters. 99(2). 185–189. 56 indexed citations
15.
Searle, Norman R., et al.. (1995). An evaluation of the N-CAT, a new arterial tonometer. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 42(6). 526–531. 3 indexed citations
16.
Moss, Neil, Pierre L. Beaulieu, Jean‐Simon Duceppe, et al.. (1995). Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents. Journal of Medicinal Chemistry. 38(18). 3617–3623. 26 indexed citations
17.
Ricco, Jean‐Baptiste, et al.. (1991). Remote Arteriovenous Fistula with Infrapopliteal Polytetrafluoroethylene Bypass for Critical Ischemia. Annals of Vascular Surgery. 5(6). 525–528. 4 indexed citations
18.
Fazal, Gulrez, et al.. (1991). A new solid phase strategy for the synthesis of mammalian glucagon. Tetrahedron Letters. 32(5). 577–580. 5 indexed citations
19.
Ferland, Jean‐Marie, et al.. (1989). Photolabile p-methoxyphenacyloxycarbonyl group for the protection of amines. Tetrahedron Letters. 30(15). 1901–1904. 11 indexed citations
20.
Duceppe, Jean‐Simon & Jean Gauthier. (1984). Synthesis of 5H‐imidazo[2,1‐c]pyrrolo[1,2‐a][1,4]benzodiazepine. Journal of Heterocyclic Chemistry. 21(6). 1685–1687. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026